CORE LABORATORIES INC (CLB)

US21867A1051 - Common Stock

24.01  -0.55 (-2.24%)

After market: 24.01 0 (0%)

Buy % Consensus

48

ChartMill assigns a Buy % Consensus number of 48% to CLB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 23.97. This target is -0.17% below the current price.
CLB was analyzed by 15 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about CLB.
In the previous month the buy percentage consensus was at a similar level.
CLB was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 24.0119.1921.9323.9732.55 - -20.07% -8.66% -0.17% 35.57%

Related screens

Up and Down Grades
Date Firm Action Rating
2023-09-18 Citigroup Maintains Sell -> Sell
2023-07-31 Piper Sandler Maintains Neutral -> Neutral
2023-06-30 Citigroup Downgrade Neutral -> Sell
2023-05-01 Piper Sandler Maintains Neutral
2023-04-28 Stifel Maintains Hold
2023-04-18 B of A Securities Downgrade Neutral -> Underperform
2023-02-07 Citigroup Maintains Neutral
2023-01-09 B of A Securities Upgrade Underperform -> Neutral
2022-10-07 Citigroup Upgrade Sell -> Neutral
2022-09-26 Morgan Stanley Downgrade Equal-Weight -> Underweight
2022-08-01 Morgan Stanley Maintains Equal-Weight
2022-07-13 Morgan Stanley Maintains Equal-Weight
2022-05-02 Morgan Stanley Maintains Equal-Weight
2022-04-18 Piper Sandler Downgrade Neutral -> Underweight
2022-04-11 Morgan Stanley Maintains Equal-Weight
2022-01-18 Morgan Stanley Maintains Equal-Weight
2021-12-07 Morgan Stanley Maintains Equal-Weight
2021-10-18 B of A Securities Downgrade Neutral -> Underperform
2021-10-11 Morgan Stanley Maintains Equal-Weight
2021-08-03 Morgan Stanley Maintains Equal-Weight
2021-07-09 Morgan Stanley Downgrade Overweight -> Equal-Weight
2021-06-14 Citigroup Downgrade Neutral -> Sell
2021-03-25 Morgan Stanley Maintains Overweight